Jagsonpal Pharmaceuticals Ltd - Share Price
JAGSNPHARM
Jagsonpal Pharmaceuticals LtdFinancials
Jagsonpal Pharmaceuticals LtdNews & Updates
Jagsonpal Pharma slumps 4% after expecting Covid-19 impact on collections on FY20
Jul 01,2020 02:48 PM
In view of the outbreak of the Coronavirus pandemic the companys registered office including all branches operations are temporari
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 485.55 | 39.10 | 116,523.70 | 531.95 | 0.82 | 2,878.64 | 101.68 |
| Dr Reddys Laboratories Ltd | 5,022.00 | 25.01 | 83,527.04 | 950.20 | 0.50 | 3,244.40 | 919.75 |
| Divis Laboratories Ltd | 3,093.50 | 51.27 | 81,914.31 | 492.25 | 0.52 | 1,709.96 | 275.61 |
| Cipla Ltd | 757.50 | 27.33 | 61,070.11 | 610.30 | 0.53 | 3,035.72 | 215.82 |
| Biocon Ltd | 429.65 | 146.59 | 51,540.00 | 84.80 | 0.00 | 520.70 | 62.80 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Jagsonpal Pharmaceuticals LtdSummary & Reports
No Company Summary found
Registered Office
T-210 J,Shahpur Jat,New Delhi, New Delhi,110049
Tell. : +91-011-46181100/46109900
Website : http://www.jagsonpal.com
Email : cs@jagsonpal.com
Registrar Office
F-65 1st Floor, Phase-I, New Delhi-110020 INDIA
Tell. : +91-11-41406149-52
Website : www.mcsdel.com
Email : mcsdel@vsnl.com
Reports by jagsonpal-pharmaceuticals-ltd
Latest Release by jagsonpal-pharmaceuticals-ltd
Result Express
Shareholding Snapshot
Loading ...
| Sep - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 70.34% |
| Total Promoter | 70.34% |
| Non Promoter | - |
| Institutions | 0.00% |
| Non-Institutions | 29.66% |
| Total Non-Promoter | 29.66% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
AGM
Exp. Date
30 Sep 2020
Annc. Date
05 Sep 2020
Intimation for Notice of 41st Annual General Meeting to be held through Video Conferencing or Other ... More
Purpose
Dividend
Annc. Date
29 Jul 2020
Effective. Date
22 Sep 2020
Divi. Type
Final
Divi.(%)
10
Divi. Amt.
0.5
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its mee... More
Purpose
Board Meeting
Exp. Date
29 Jul 2020
Annc. Date
24 Jul 2020
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Com... More
Purpose
Board Meeting
Exp. Date
13 Feb 2020
Annc. Date
03 Feb 2020
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Com... More
